Joseph Lucchese

Joe is the Chief Financial Officer of Timber Pharmaceuticals as well as a Partner at TardiMed Sciences. Prior to joining TardiMed, he was a founding member and Managing Director of Oncology Partners, a boutique financial advisory firm serving development stage biotechnology companies and investors. Prior to founding Oncology Partners, Joe was a Managing Partner of Foundation Ventures, an investment banking firm servicing early stage life sciences companies.

Joe was also a Managing Director at BlueStone Capital Partners where he ran the Private Placement desk. Prior to BlueStone, Joe was Portfolio Manager and Chief Financial Officer of the MicroCap Fund, a NASDAQ-listed private equity fund that invested in early stage companies in the healthcare and information technology sectors.

Joe has served as a board member and a founding partner in numerous companies during the course of his career. He began his career as a member of Chase Manhattan Bank’s Merchant Banking Group where he was part of a team that financed highly leveraged transactions and managed the bank’s private equity portfolio. Joe has a BS in Finance from Fordham University.